Skip to content

Study of Surgery in Patients With Idiopathic Macular Hole

A Randomized, Double-masked, Multicenter, Controlled Study of Effects of Internal Membrane Peeling Surgery in Patients With Idiopathic Macular Hole Measured by Optical Coherence Tomography.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02905409
Enrollment
228
Registered
2016-09-19
Start date
2016-08-31
Completion date
2020-06-30
Last updated
2019-12-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Macular Hole, Surgery

Brief summary

The purpose of this study is to determine the effects of two different internal limiting membrane peeling with distinct diameters after macular hole surgery on anatomical closure grades.

Detailed description

The purpose of this study is to investigate two distinct diameter of internal limiting membrane peeling on anatomical outcomes of macular hole surgery with different preoperative idiopathic macular hole.

Interventions

4PD or 2PD diameter of ILM peeling in surgery was given to patients with IMH (idiopathic macular hole)

Sponsors

Beijing Tongren Hospital
CollaboratorOTHER
Beijing Hospital
CollaboratorOTHER_GOV
Peking Union Medical College Hospital
CollaboratorOTHER
Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients with IMH * patients signed the ICF * patients with course of IMH less than 3 years

Exclusion criteria

* patients with hyper myopia * patients with traumatic macular hole * accompanied or secondary of other fundus disease * open or reopen after receiving MH surgery * patients with retinal detachment * received vitrectomy due to other diseases * glaucoma cannot be controled by medication * patients with other retinal or choroidal disease that may affect VA * poor patients compliance * poor condition that cannot undertake the surgery * dioptric media opacities which make it difficult to exam fundus or measure on OCT

Design outcomes

Primary

MeasureTime frameDescription
Anatomical closure grades in OCT6 monthsThe anatomical outcomes were defined as good closure and poor closure.
Change of anatomical closure grades in OCT1 month, 3 months, 6 months, 1 yearThe anatomical outcomes were defined as good closure and poor closure.

Secondary

MeasureTime frameDescription
Change from baseline in BCVA (best corrected visual acuity).1 month, 3 months, 6 months, 1 yearBCVA were measured by ETDRS chart.

Countries

China

Contacts

Primary ContactMingwei Zhao, M.D
dr_mingweizhao@163.com13801057408

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026